Cargando...

Oncolytic Virotherapy for the Treatment of Malignant Glioma

Malignant glioma is the most common primary brain tumor and carries a grim prognosis, with a median survival of just over 14 months. Given the poor outcomes with standard-of-care treatments, novel treatment strategies are needed. The concept of virotherapy for the treatment of malignant tumors dates...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neurotherapeutics
Main Authors: Foreman, Paul M., Friedman, Gregory K., Cassady, Kevin A., Markert, James M.
Formato: Artigo
Idioma:Inglês
Publicado: Springer International Publishing 2017
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5398989/
https://ncbi.nlm.nih.gov/pubmed/28265902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-017-0516-0
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!